723 related articles for article (PubMed ID: 9023367)
1. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
[TBL] [Abstract][Full Text] [Related]
2. In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32.
Tange TO; Jensen TH; Kjems J
J Biol Chem; 1996 Apr; 271(17):10066-72. PubMed ID: 8626563
[TBL] [Abstract][Full Text] [Related]
3. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
4. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
Caputi M; Freund M; Kammler S; Asang C; Schaal H
J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
[TBL] [Abstract][Full Text] [Related]
5. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
6. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
[TBL] [Abstract][Full Text] [Related]
7. The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements.
Bogerd HP; Huckaby GL; Ahmed YF; Hanly SM; Greene WC
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5704-8. PubMed ID: 1905815
[TBL] [Abstract][Full Text] [Related]
8. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
Dauksaite V; Akusjärvi G
Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
[TBL] [Abstract][Full Text] [Related]
9. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
10. Positive and negative modulation of human immunodeficiency virus type 1 Rev function by cis and trans regulators of viral RNA splicing.
Pongoski J; Asai K; Cochrane A
J Virol; 2002 May; 76(10):5108-20. PubMed ID: 11967326
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
[TBL] [Abstract][Full Text] [Related]
12. PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA.
Invernizzi CF; Xie B; Richard S; Wainberg MA
Retrovirology; 2006 Dec; 3():93. PubMed ID: 17176473
[TBL] [Abstract][Full Text] [Related]
13. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.
Belshan M; Park GS; Bilodeau P; Stoltzfus CM; Carpenter S
Mol Cell Biol; 2000 May; 20(10):3550-7. PubMed ID: 10779344
[TBL] [Abstract][Full Text] [Related]
14. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
15. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
Shih SR; Krug RM
EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
[TBL] [Abstract][Full Text] [Related]
16. Effect of Rev on the intranuclear localization of HIV-1 unspliced RNA.
Favaro JP; Borg KT; Arrigo SJ; Schmidt MG
Virology; 1998 Sep; 249(2):286-96. PubMed ID: 9791020
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
Wang J; Xiao SH; Manley JL
Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.
Venkatesan S; Gerstberger SM; Park H; Holland SM; Nam Y
J Virol; 1992 Dec; 66(12):7469-80. PubMed ID: 1433526
[TBL] [Abstract][Full Text] [Related]
19. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.
Tange TØ; Kjems J
J Mol Biol; 2001 Sep; 312(4):649-62. PubMed ID: 11575921
[TBL] [Abstract][Full Text] [Related]
20. Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.
Cmarko D; Bøe SO; Scassellati C; Szilvay AM; Davanger S; Fu XD; Haukenes G; Kalland KH; Fakan S
J Virol; 2002 Oct; 76(20):10473-84. PubMed ID: 12239324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]